Prometrium Cost in Arkansas (2026): Cash Prices, Medicaid, and Savings Options

What Prometrium Actually Costs at Arkansas Pharmacies

The gap between the sticker price and what you pay is wide. AbbVie lists brand-name Prometrium at roughly $180 per month for a 30-count supply of 200 mg capsules. Very few patients in Arkansas pay that figure. Generic micronized progesterone (the same FDA-approved drug substance in a peanut-oil base) averages about $45 per month at retail pharmacies statewide.

Prices vary by pharmacy. A Walmart or Kroger in Little Rock may charge $38 for a 30-day supply, while an independent pharmacy in Fayetteville might quote $52. Checking multiple pharmacies, even within the same city, can save $10 to $15 per fill. Using a discount card (GoodRx, RxSaver, or the AbbVie savings card) often drops the price below $30 for the generic.

Compounded micronized progesterone from a licensed 503A compounding pharmacy typically costs around $25 per month in Arkansas. That option works for patients who need a peanut-oil-free formulation or a non-standard dose, but the compounded product is not AB-rated interchangeable with Prometrium and does not carry its own FDA approval for the finished dosage form 1.

The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial, a landmark NIH-funded study of 875 postmenopausal women, established that oral micronized progesterone provides endometrial protection comparable to medroxyprogesterone acetate while producing a more favorable lipid profile 2. That trial is a primary reason clinicians prescribe Prometrium rather than synthetic progestins for women on estrogen HRT.

Arkansas Medicaid Coverage and Prior Authorization

Arkansas Medicaid does cover Prometrium. It is not open-access. You will need a prior authorization (PA) before the state program pays for it. The PA process requires the prescriber to document a medical reason for micronized progesterone specifically, such as intolerance to medroxyprogesterone acetate or an indication tied to its FDA labeling.

The Arkansas Department of Human Services Pharmacy Program uses a preferred drug list (PDL) that changes annually. As of early 2026, generic micronized progesterone sits in a tier that requires PA for Medicaid fee-for-service enrollees. Managed care organizations (MCOs) administering Arkansas Medicaid may have slightly different formulary rules, so the PA criteria can differ depending on whether a patient is enrolled in Arkansas Total Care, Help Healthcare Solutions, or Summit Community Care.

A prescriber submitting a PA for Prometrium or its generic typically needs to include the diagnosis code (most commonly Z79.890 for long-term HRT or N91.1 for secondary amenorrhea), the dose and duration, and a brief clinical rationale. Turnaround time for Arkansas Medicaid PA decisions is usually 24 to 72 hours. Urgent requests can be processed in under 24 hours per federal Medicaid rules under 42 CFR § 438.210.

The 2022 Endocrine Society clinical practice guideline on menopausal hormone therapy recommends micronized progesterone as the preferred progestogen for endometrial protection in women using systemic estrogen, citing lower breast cancer risk signals compared to synthetic progestins 3. That guideline language can support PA requests when a Medicaid reviewer asks why medroxyprogesterone is not acceptable.

Commercial Insurance Coverage in Arkansas

Most employer-sponsored and ACA marketplace plans sold in Arkansas cover generic micronized progesterone on Tier 1 or Tier 2. Brand-name Prometrium, when available, is usually Tier 3 with a higher copay. Some plans impose step therapy: the patient must try the generic first, and only if there is a documented failure or allergy does the plan cover brand.

Blue Cross Blue Shield of Arkansas, the state's largest commercial insurer, lists generic micronized progesterone on its standard formulary. QualChoice, another major Arkansas carrier, also includes it. Copays for generic micronized progesterone under commercial plans typically range from $5 to $25 per month, depending on the plan's pharmacy benefit design.

For patients with high-deductible health plans (HDHPs), the full cash price applies until the deductible is met. That makes the $45 average cash-pay price relevant even for insured patients early in the plan year. A discount card may beat the insurance-negotiated rate in those months.

The Women's Health Initiative (WHI) data published in JAMA in 2002 drove many women and clinicians away from all hormone therapy for years 4. Subsequent reanalysis, including the 2017 WHI follow-up in JAMA, clarified that much of the excess breast cancer risk was linked to the combination of conjugated equine estrogen plus medroxyprogesterone acetate, not to micronized progesterone 5. That distinction has driven a clinical shift toward Prometrium and its generics. As Dr. JoAnn Manson, the WHI principal investigator, stated in a 2020 NEJM editorial: "The type and route of progestogen matters. Micronized progesterone and transdermal estradiol may carry a lower risk profile than the oral conjugated estrogen plus medroxyprogesterone regimen tested in the WHI" 6.

Compounded Micronized Progesterone in Arkansas

Compounded micronized progesterone is legal in Arkansas when dispensed by a pharmacy operating under a valid 503A license. Section 503A of the Federal Food, Drug, and Cosmetic Act permits pharmacies to compound medications based on individual patient prescriptions, provided the pharmacy meets state board of pharmacy requirements and does not engage in large-scale manufacturing 7.

The Arkansas State Board of Pharmacy regulates compounding pharmacies within the state. Several 503A pharmacies in Little Rock, Fayetteville, Jonesboro, and Fort Smith compound micronized progesterone capsules, troches, or topical creams. Prices for compounded oral capsules average $25 per month, sometimes lower for 90-day supplies.

There are trade-offs. Compounded products do not undergo the same bioequivalence testing as FDA-approved generics. A 2023 FDA survey of compounded hormone therapy products found that 15 out of 40 tested samples (37.5%) failed potency specifications 8. The North American Menopause Society (NAMS) 2022 position statement advises clinicians to use FDA-approved hormone therapy formulations when available, and to reserve compounded bioidentical hormones for cases where a patient needs a dose or delivery form not commercially available 9.

For patients considering compounded progesterone in Arkansas, the key questions to ask the compounding pharmacy are: Does the pharmacy hold a current 503A license? Does it participate in third-party potency verification? What is the beyond-use date assigned to the product?

Telehealth Prescribing in Arkansas

Arkansas allows telehealth prescribing of Prometrium. The state updated its telemedicine regulations under Act 887 of 2019 and subsequent amendments, permitting prescribers to establish a patient-provider relationship via synchronous audio-video visit for non-controlled substances. Micronized progesterone is not a controlled substance in Arkansas or federally.

That means a patient in Pine Bluff, Hot Springs, or Texarkana can see an HRT prescriber by video, receive a Prometrium prescription electronically, and fill it at any licensed Arkansas pharmacy or through a mail-order pharmacy. HealthRX and similar telehealth platforms offer hormone therapy consultations for Arkansas residents.

Telehealth access matters in Arkansas particularly because 20 of the state's 75 counties are classified as health professional shortage areas (HPSAs) for primary care by the Health Resources and Services Administration (HRSA) 10. In rural counties with limited OB/GYN or endocrinology access, telehealth is sometimes the only practical way to get an HRT prescription without driving two or more hours.

How the AbbVie Savings Card Works

AbbVie (which acquired the Prometrium brand through the Allergan/Solvay lineage) offers a manufacturer savings card for brand-name Prometrium. The card reduces out-of-pocket costs for commercially insured patients. It does not apply to patients on Medicaid, Medicare Part D, Tricare, or other government-funded programs.

With the savings card, eligible patients typically pay $0 to $35 per month for brand Prometrium. The card covers the difference between the patient's copay and the savings card maximum (usually $150 per fill). Patients can enroll online through the AbbVie prescription savings portal or receive a card from their prescriber's office.

The savings card resets annually and has an annual maximum benefit, often $1,800 per year. For patients who would otherwise pay a $50 to $75 brand copay, this card can cut the annual cost from roughly $600 to $900 down to $0 to $420. Pharmacy staff at Walgreens, CVS, and most Arkansas independents can process the card at the point of sale alongside the patient's insurance card.

How to Get the Lowest Price in Arkansas

The cheapest path depends on your insurance status. For commercially insured patients with a low generic copay ($5 to $15), the most cost-effective option is generic micronized progesterone filled through the insurance benefit. No extra steps needed.

For uninsured or high-deductible patients, three strategies compete:

1. Discount card at a retail pharmacy. GoodRx, RxSaver, or SingleCare often bring the 30-day generic price below $30 at Walmart, Costco (no membership required for pharmacy), or Kroger locations across Arkansas.

2. Compounded micronized progesterone. At $25 per month from a licensed 503A pharmacy, this is the lowest absolute price. The trade-off is the lack of FDA bioequivalence testing on the finished capsule.

3. Mail-order pharmacy. Some mail-order pharmacies offer 90-day supplies of generic micronized progesterone for $90 to $100, which works out to $30 to $33 per month. The convenience of home delivery adds value for patients in rural Arkansas counties.

For Medicaid patients, the out-of-pocket cost after PA approval is typically $0 to $3 per prescription under Arkansas Medicaid fee-for-service copay rules.

The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 141 on the management of menopausal symptoms recommends using the lowest effective dose of progestogen for the shortest duration consistent with treatment goals 11. For most women on cyclic HRT, that means 200 mg of micronized progesterone for 12 to 14 days per month. For continuous combined regimens, the dose drops to 100 mg daily. Paying for 12 to 14 capsules per month rather than 30 can cut costs by more than half for patients on cyclic regimens.

Arkansas-Specific Discount Programs

Arkansas does not operate a state-funded prescription assistance program comparable to those in New York (EPIC) or Pennsylvania (PACE). The state's low-income prescription help comes primarily through Medicaid and the ARKids First program for children, the latter of which does not cover menopause-related HRT.

Patients who fall into the coverage gap (income too high for Medicaid, too low for ACA marketplace subsidies) can access the AbbVie Patient Assistance Foundation for brand Prometrium at no cost, provided household income is below 400% of the federal poverty level. The application requires proof of income, proof of Arkansas residency, and a prescriber signature.

Community health centers (FQHCs) in Arkansas, such as Boston Mountain Rural Health Centers in the northwest part of the state and ARcare in the Delta, operate 340B pharmacy programs. Under 340B pricing, these health centers purchase medications at deeply discounted rates and pass savings to qualifying patients. Generic micronized progesterone through a 340B-eligible FQHC pharmacy may cost $10 to $20 per month.

The E3N French cohort study, which followed 80,377 postmenopausal women, found that the combination of transdermal estradiol and oral micronized progesterone was not associated with increased breast cancer risk over a mean follow-up of 8.1 years (RR 1.00, 95% CI 0.83 to 1.22) 12. That finding, while observational, is one reason many HRT prescribers now pair transdermal estrogen with oral Prometrium rather than synthetic progestins.